je.st
news
DexCom Announces Appointment of Mark G. Foletta as Board Member
2014-11-20 13:05:04| Steel - Topix.net
Mr. Foletta currently serves on the board of directors of AMN Healthcare Services and Regulus Therapeutics. Previously, Mr. Foletta served as Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc. from 2006 to August 2012 during the growth of Amylin's diabetes and obesity franchises, including the commercial launch of diabetes drugs BYDUREONA , BYETTAA and SYMLINA .
Tags: member
board
mark
appointment
Category:Materials
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||